The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant icotinib versus observation in patients with completely resected, EGFR-mutated, stage IB non–small cell lung cancer (GASTO1003, CORIN): A randomized phase II trial.
 
Ning Li
No Relationships to Disclose
 
Bao-Xiao Wang
No Relationships to Disclose
 
Wei Ou
No Relationships to Disclose
 
Hena Shi
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Honoraria - Betta Pharmaceuticals
Travel, Accommodations, Expenses - Betta Pharmaceuticals
 
Dong Ji
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Honoraria - Betta Pharmaceuticals
Travel, Accommodations, Expenses - Betta Pharmaceuticals
 
Yan Yan
Employment - Betta Pharmaceuticals
Honoraria - Betta Pharmaceuticals
Travel, Accommodations, Expenses - Betta Pharmaceuticals
 
Shu-Quan Wang
No Relationships to Disclose
 
Wu-Guang Chang
No Relationships to Disclose
 
Teng-Fei Zhu
No Relationships to Disclose
 
Si-Yu Wang
No Relationships to Disclose